Keith Mansford
Director/Board Member at Mindset BioPharmaceuticals Ltd.
Network origin in Keith Mansford first degree
Entity | Entity type | Industry | |
---|---|---|---|
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel.
6
| Private Company | Medical/Nursing Services | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Keith Mansford via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
W WORL | Pharmaceuticals: Major | Corporate Officer/Principal | |
REPLIGEN CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Pharmaceuticals: Major | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Graduate Degree | |
Brandeis University | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Doctorate Degree | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree | |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Pharmaceuticals: Major | Director/Board Member | |
London School of Economics & Political Science | College/University | Undergraduate Degree | |
Deaconess Hospital (Oklahoma)
Deaconess Hospital (Oklahoma) Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Deaconess Hospital is a 313-bed hospital based in Oklahoma City, OK. The hospital provides medical services to patients in the area. | Hospital/Nursing Management | Corporate Officer/Principal | |
Universidad de Buenos Aires | College/University | Corporate Officer/Principal | |
Weizmann Institute of Science | College/University | Doctorate Degree | |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Proficiency Ltd. | Director of Finance/CFO | ||
Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | ||
MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member | |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Founder | |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
PURPLE BIOTECH LTD | Pharmaceuticals: Major | General Counsel | |
Harvard College | College/University | Undergraduate Degree | |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Biotechnology | Director/Board Member | |
Dapis Capital LLC | Founder | ||
UBS Oncology Impact Fund
UBS Oncology Impact Fund Investment ManagersFinance UBS Oncology Impact Fund is an American private company located in Cambridge, MA, with a presence in the Cayman Islands, that functions as a family of funds. | Investment Managers | Director/Board Member | |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
FameWave Ltd.
FameWave Ltd. Pharmaceuticals: MajorHealth Technology FameWave Ltd. is a biopharmaceutical company engaging in the development of medications for the treatment of cancer. Its product is CM-24. The company was founded on July 2, 2017 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
Matrivax Research & Development Corp.
Matrivax Research & Development Corp. BiotechnologyHealth Technology Matrivax Research & Development Corp. is developing human vaccines for the prevention and treatment of life-threatening bacterial diseases. Its pipeline includes two vaccine candidates implementing proprietary streptococcus pneumoniae and clostridium difficile protective antigens. The company was founded in October 2007 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer | |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chairman | |
Bioimpact Capital LLC
Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Renagade Therapeutics, Inc.
Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder |
Statistics
International
United States | 35 |
Israel | 9 |
United Kingdom | 6 |
France | 2 |
Argentina | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 10 |
Commercial Services | 6 |
Finance | 6 |
Miscellaneous | 2 |
Operational
Director/Board Member | 58 |
Corporate Officer/Principal | 26 |
Independent Dir/Board Member | 8 |
Founder | 7 |
Chairman | 5 |
Most connected contacts
- Stock Market
- Insiders
- Keith Mansford
- Company connections